跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
P-55
首页
药物
P-55
P-55
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
METHODS OF DETERMINING WHETHER A SUBJECT HAS OR IS AT RISK OF HAVING A CENTRAL SEROUS CHORIORETINOPATHY
EP 4118235 A1
申请人: INST NAT SANTE RECH MED
优先权: 2020
EP
US
WO
4 件公开
Triglyceride fat
US 2005220965 A1
申请人: FLOETER ECKHARD
优先权: 2002
US
2 件公开
Bone repair putty
US 7842300 B2
申请人: DENTSPLY INT INC
优先权: 2003
US
2 件公开
US 8876532 B2
申请人: ATKINSON BRENT L
优先权: 2010
US
2 件公开
Cosmetic and topical skin preparation comprising higher alcohol-modified silicone
US 9283164 B2
申请人: FURUKAWA HARUHIKO
优先权: 2010
US
2 件公开
Synthetic method of 2-furanacrylonitrile as fuvinazole drug intermediate
CN 105503793 A
申请人: CHENGDU ZHONGHENG HUATIE TECH CO LTD
优先权: 2015
CN
2 件公开
Antineoplastic compound intercedenside A
CN 1133645 C
申请人: LIMITARY MEDICAL UNIV NO 2 PLA
优先权: 2002
CN
Group I mite polypeptide variants
US 2005142641 A1
申请人: NOVOZYMES AS
优先权: 2004
US
Methods for enhancing engraftment of purified hematopoietic stem cells in allogenic recipients
US 2007098693 A1
申请人: ILDSTAD SUZANNE T
优先权: 2004
US
Water-soluble vitamin formulation containing sodium calcium ethylene diamine tetracetate for injection and its preparation method
CN 1839874 A
申请人: WUXI KAIFU PHARMACEUTCIAL CO L
优先权: 2005
CN
Production method of odor-masking enrofloxacin
CN 1839841 A
申请人: XINCHANG GUOBANG CHEMICAL IND
优先权: 2006
CN
第 1 / 8 页
上一页
下一页
药物
反馈